SerpinA3N deficiency deteriorates impairments of learning and memory in mice following hippocampal stab injury.
Zhi-Meng WangCong LiuYing-Ying WangYu-Sen DengXuan-Cheng HeHong-Zhen DuChang-Mei LiuZhao-Qian TengPublished in: Cell death discovery (2020)
Traumatic brain injury is a global leading cause of disability and death, which puts patients at high risk for developing dementia. Early intervention is believed as the key to minimize the development of brain damages that could aggravate the symptoms. Here, we report that the serine protease inhibitor SerpinA3N is upregulated in hippocampal neurons in the early stage of hippocampal stab injury (HSI), while its deficiency causes a greater degree of neuronal apoptosis and severer impairments of spatial learning and memory in mice after HSI. We further show that MMP2 is a key substrate of SerpinA3N, and MMP2 specific inhibitor (ARP100) can protect against neuronal apoptosis and cognitive dysfunction in mice after HSI. These findings demonstrate a critical role for SerpinA3N in neuroprotection, suggesting that SerpinA3N and MMP2 inhibitors might be a novel therapeutic agents for neurotrauma.
Keyphrases
- cerebral ischemia
- traumatic brain injury
- early stage
- high fat diet induced
- subarachnoid hemorrhage
- oxidative stress
- end stage renal disease
- brain injury
- endoplasmic reticulum stress
- blood brain barrier
- randomized controlled trial
- cell cycle arrest
- ejection fraction
- cell migration
- newly diagnosed
- cell death
- multiple sclerosis
- peritoneal dialysis
- metabolic syndrome
- mild cognitive impairment
- wild type
- cognitive impairment
- prognostic factors
- radiation therapy
- type diabetes
- temporal lobe epilepsy
- insulin resistance
- squamous cell carcinoma
- depressive symptoms
- cell proliferation
- protein kinase
- spinal cord injury
- skeletal muscle
- rectal cancer
- lymph node
- locally advanced